Across TCGA pan-cancer cohorts, UGT1A11P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated UGT1A11P data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher UGT1A11P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated UGT1A11P expression acts as an unfavorable survival marker, although some lineages such as KIRC and UCS show a favorable association.
BLCA, COAD, and KIRC are the cancer types where UGT1A11P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.